Found: 9
Select item for more details and to access through your institution.
Correction to: Mavacamten: First Approval.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1165, doi. 10.1007/s40265-022-01755-7
- By:
- Publication type:
- Article
New Developments in Glucagon Treatment for Hypoglycemia.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1179, doi. 10.1007/s40265-022-01754-8
- By:
- Publication type:
- Article
Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1193, doi. 10.1007/s40265-022-01751-x
- By:
- Publication type:
- Article
Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1151, doi. 10.1007/s40265-022-01750-y
- By:
- Publication type:
- Article
Mosunetuzumab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1229, doi. 10.1007/s40265-022-01749-5
- By:
- Publication type:
- Article
Tapinarof Cream 1%: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1221, doi. 10.1007/s40265-022-01748-6
- By:
- Publication type:
- Article
Tirzepatide: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1213, doi. 10.1007/s40265-022-01746-8
- By:
- Publication type:
- Article
Desidustat: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 11, p. 1207, doi. 10.1007/s40265-022-01744-w
- By:
- Publication type:
- Article